Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesKelyniam Global Inc

Kelyniam Global Inc

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
0.1 USD 0.00(0%)
Last update at 2026-11-05T21:00:00Z
VOLUME
800
Market Cap
5.92M

Momentum Score

…

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Canton, Connecticut.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.10
High
52 Week Price Range
0.07
Low
0.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Kelyniam Global Inc (KLYG.PK) are limited and the company does not provide clear, consistent detail on its core business or operations. Because material growth drivers are not disclosed, investors cannot verify long-term prospects, though microcap issuers may attract attention if operations scale or management executes a credible plan.
Primary investment risks include the lack of transparent, up-to-date disclosures, the OTC Pink listing with low liquidity, potential for dilution and governance uncertainty, all of which create significant information and execution risk.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.10
Dividend Yield
-
Revenue TTM
2.67M
Revenue Per Share
0.09
Gross Profit TTM
2.04M
Debt / Equity
0.63
ROE
-31.64%
Net Debt
0.40M
ROCE
-10.41%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.20M -1.14M -0.37M - -
Net income -0.14M -0.92M -0.22M - -
Selling general administrative - - 0.43M - -
Selling and marketing expenses - - 0.94M - -
Gross profit 2.30M 1.63M 2.04M - -
Ebit -0.11M -1.04M -0.25M -0.03M 0.23M
Ebitda -0.06M -1.00M -0.20M - -
Depreciation and amortization 0.05M 0.05M 0.05M - -
Operating income -0.11M -0.63M -0.24M - -
Other operating expenses 3.16M 3.96M 2.91M 0.05M 0.05M
Interest expense 0.09M 0.10M 0.09M - 0.00M
Income tax expense -0.06M -0.22M -0.15M -0.03M 0.03M
Total revenue 3.05M 3.33M 2.67M - -
Total operating expenses 2.41M 2.26M 2.28M - -
Cost of revenue 0.75M 1.69M 0.64M - -
Total other income expense net -0.09M -0.51M -0.13M - -
Net income applicable to common shares - - - -0.10M 0.20M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1.75M 1.77M 1.63M - -
Intangible assets - 0.02M 0.01M - -
Other current assets 0.00M 0.00M 0.00M - -
Total liab 0.94M 0.88M 1.01M - -
Total stockholder equity 0.81M 0.88M 0.62M - -
Other current liab 0.29M 0.33M 0.13M 0.04M 0.15M
Common stock 0.05M 0.05M 0.03M 0.03M 0.03M
Retained earnings -3.34M -3.20M -2.28M -2.06M -1.96M
Other assets - - 0.00M 0.47M 0.44M
Cash 0.10M 0.15M 0.01M - -
Total current liabilities 0.72M 0.59M 0.69M 0.69M 0.69M
Current deferred revenue - - 0.00M - -
Net debt 0.40M 0.27M 0.62M - -
Short term debt 0.29M 0.13M 0.31M - -
Short long term debt total 0.51M 0.42M 0.63M - -
Other stockholder equity 4.10M 4.03M 2.87M - -
Property plant equipment - - - 0.58M 0.40M
Total current assets 0.56M 0.57M 0.51M 0.66M 0.59M
Net tangible assets - - - 0.76M 0.69M
Net receivables 0.41M 0.39M 0.45M 0.50M 0.54M
Inventory 0.04M 0.03M 0.05M 0.06M 0.04M
Accounts payable 0.14M 0.14M 0.25M 0.25M 0.11M
Accumulated other comprehensive income - - 0.00M - -
Non currrent assets other 0.01M 0.01M 0.62M - -
Non current assets total 1.19M 1.19M 1.13M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Change to liabilities - - - 0.00M 0.09M
Total cashflows from investing activities - -0.01M - -0.05M -0.01M
Net borrowings - - - 0.08M -0.13M
Total cash from financing activities 0.15M 0.05M 0.10M 0.08M -0.13M
Change to operating activities - - - -0.17M -0.06M
Net income -0.14M -0.92M -0.22M -0.10M 0.20M
Change in cash -0.05M 0.14M 0.01M - -
Begin period cash flow 0.15M 0.01M 0.00M - -
End period cash flow 0.10M 0.15M 0.01M - -
Total cash from operating activities -0.19M 0.10M -0.10M -0.03M 0.14M
Depreciation 0.05M 0.05M 0.05M 0.05M 0.04M
Other cashflows from investing activities - - -0.00M - -
Change to inventory -0.01M 0.01M 0.01M -0.01M 0.04M
Change to account receivables -0.03M 0.06M 0.05M 0.04M -0.26M
Other cashflows from financing activities -0.01M -0.08M -0.03M - -
Change to netincome - - - 0.17M 0.09M
Capital expenditures 0.00M 0.01M 0.00M 0.05M 0.01M
Change in working capital -0.17M 0.17M 0.18M - -
Stock based compensation - - 0.08M - -
Other non cash items 0.07M 1.04M -0.04M - -
Free cash flow -0.19M 0.10M -0.10M - -

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
KLYG
Kelyniam Global Inc		 -
-%		 0.10 - - 2.21 - 75.85 -9.48
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

Kelyniam Global Inc

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and changed its name to Kelyniam Global, Inc. in December 2007. Kelyniam Global, Inc. was incorporated in 2005 and is based in Canton, Connecticut.

97 River Road, Canton, CT, United States, 06019

800 280 8192

https://www.kelyniam.com

Name Title Year Born
Mr. Ross Bjella Chairman & CEO 1962
Mr. Terrance Kurtenbach Chief Financial Officer NA
Michael Hamblett Director of Investor Relations NA
Mr. James Barrow Esq. Gen. Counsel and Director of Quality & Regulatory NA
Dr. Mark V. Smith M.D. VP of Sales & Bus. Devel. and Director NA
Dr. Christopher Mirucki Chief Medical Officer NA
Mr. Kris Renton Chief Revenue Officer & VP of Operations NA
Mr. James Barrow Esq. General Counsel and Director of Quality & Regulatory NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…